Besides increasing revenues I think there are other critical factors to take into consideration when assessing CTDH. This is what I am looking for:
- Increases revenue with lower profit margins >> seems maybe paradoxical but this is one metric indicating proof of concept...namely that there is a market for custom wholesale cyclodextrin compounds (i.e.NSP)
- New accounts/marketing channels/partners etc. respective of sales volume >> indicating additional customers rather than relying on historical customers
- News about sales/marketing plan (....way overdue in my humble opinion)
I actually think that right now is probably not a very good time to be selling but he, everybody there thing. Feels to me we are coming close to the end of the beginning so right now a "hold" attitude seems to me the most prudent thing to do...
Market Data 
Markets 
AI
